Respiratory Technology
Our preference is to find opportunities that are on-market, market-ready, or require limited development.
Background:
Opportunities may consist of new product forms, packaging innovations, delivery technologies, or new products.
Description of the need:
We are interested in opportunities (i.e. products and technologies) that complement our Respiratory portfolio (DayQuil, NyQuil, Sinex and ZzzQuil) and are capable of delivering any or all of the following benefits:
Providing new, or augmenting already established health claims
Increasing consumer satisfaction
Enhancing consumer compliance
Enabling greater convenience
Areas of interest are:
Technology Delivery methods (e.g. targeted, faster, delayed, etc.)
Products with claimable health benefits
New and novel product forms
New packaging (e.g., portable, convenient, etc.)
Opportunities must have (where applicable):
Human clinical data
Human safety data, NDI designation, or GRAS status
Stability data
Freedom to market
We are not interested in:
Opportunities that require extensive technical or clinical development
Opportunities with unknown regulatory path
Opportunities that require significant investment to complete their development
